AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 47 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $23,000 | -95.2% | 37,000 | -77.5% | 0.00% | -90.0% |
| Q1 2018 | $476,000 | -36.4% | 164,300 | -38.7% | 0.03% | -25.0% |
| Q4 2017 | $748,000 | -48.0% | 268,200 | -31.9% | 0.04% | -48.1% |
| Q3 2017 | $1,438,000 | +2719.6% | 394,000 | +311.3% | 0.08% | +1825.0% |
| Q4 2016 | $51,000 | -75.4% | 95,800 | -58.8% | 0.00% | -76.5% |
| Q3 2016 | $207,000 | -26.3% | 232,657 | -20.5% | 0.02% | -34.6% |
| Q2 2016 | $281,000 | +75.6% | 292,800 | +129.5% | 0.03% | +30.0% |
| Q4 2015 | $160,000 | -24.2% | 127,600 | +5.1% | 0.02% | -31.0% |
| Q2 2015 | $211,000 | -56.1% | 121,400 | -63.7% | 0.03% | -56.7% |
| Q1 2015 | $481,000 | +208.3% | 334,100 | +78.3% | 0.07% | +157.7% |
| Q4 2014 | $156,000 | +11.4% | 187,400 | +49.9% | 0.03% | +23.8% |
| Q3 2014 | $140,000 | +94.4% | 125,000 | +213.3% | 0.02% | +90.9% |
| Q2 2014 | $72,000 | +67.4% | 39,900 | +66.9% | 0.01% | +57.1% |
| Q4 2013 | $43,000 | – | 23,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $2,465,000 | 100.00% |
| New Leaf Venture Partners, L.L.C. | 2,340,673 | $8,543,000 | 3.96% |
| RA Capital Management | 11,328,646 | $41,350,000 | 3.74% |
| NEA Management Company, LLC | 16,362,694 | $59,724,000 | 2.09% |
| Avoro Capital Advisors LLC | 4,806,249 | $17,543,000 | 1.36% |
| 683 Capital Management, LLC | 2,515,810 | $9,183,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,400,000 | $5,110,000 | 0.73% |
| Perceptive Advisors | 6,830,232 | $25,110,000 | 0.48% |
| EAM Investors, LLC | 785,338 | $2,866,000 | 0.38% |
| Polar Capital LLP | 4,129,238 | $15,072,000 | 0.17% |